From owner-FreeBSD-users-jp@jp.FreeBSD.org Thu Dec 23 20:08:25 2004
Received: (from daemon@localhost)
	by castle.jp.FreeBSD.org (8.11.6p2+3.4W/8.11.3) id iBNB8P423763;
	Thu, 23 Dec 2004 20:08:25 +0900 (JST)
	(envelope-from owner-FreeBSD-users-jp@jp.FreeBSD.org)
Received: from ACC59619.ipt.aol.com (ACC59619.ipt.aol.com [172.197.150.25])
	by castle.jp.FreeBSD.org (8.11.6p2+3.4W/8.11.3) with ESMTP/inet id iBNB8N823758
	for <freebsd-users-jp@jp.freebsd.org>; Thu, 23 Dec 2004 20:08:23 +0900 (JST)
	(envelope-from vlk@guanajuato.com)
Received: from guanajuato.com (guanajuato-com.mr.outblaze.com [205.158.62.181])
	by ACC59619.ipt.aol.com with esmtp
	id C013B4B925 for <freebsd-users-jp@jp.freebsd.org>; Thu, 23 Dec 2004 13:01:33 +0100
From: "Renunciation O. Quarter" <vlk@guanajuato.com>
To: Freebsd <freebsd-users-jp@jp.FreeBSD.org>
Message-ID: <101001c4e8e7$95250f1d$c2b1624d@guanajuato.com>
MIME-Version: 1.0
Content-Type: text/plain
Content-Transfer-Encoding: 7bit
X-Priority: 3 (Normal)
X-MSMail-Priority: Normal
X-Mailer: Microsoft Outlook, Build 10.0.4024
Importance: Normal
X-MimeOLE: Produced By Microsoft MimeOLE V6.00.2800.1082
X-RAV-Antivirus: This e-mail has been scanned for viruses on host: ACC59619.ipt.aol.com
Reply-To: FreeBSD-users-jp@jp.FreeBSD.org
Precedence: list
Date: Thu, 23 Dec 2004 13:01:33 +0100
X-Sequence: FreeBSD-users-jp 82198
Subject: [FreeBSD-users-jp 82198] Freebsd 3 Month Long Stock Promotion
Sender: owner-FreeBSD-users-jp@jp.FreeBSD.org
X-Originator: vlk@guanajuato.com
X-Distribute: distribute version 2.1 (Alpha) patchlevel 24e+041222

INVESTMENT ALERT 
EMERGING BIOTECH COMPANY SOON TO RELEASE GROUND BREAKING MEDICAL DEVICE 

In Vivo Medical Diagnostics, Inc (Stock Symbol OTC: IVVO) is finalizing its first ground-breaking portable medical device, the Prothrombin Time Monitor, that measures changes in the magnetic fields of blood on a molecular level. This is critical for patients undergoing anticoagulation therapy after heart attacks and strokes.
This measurement is now portable and is used in real time to achieve optimal medication levels, which is essential for successful treatment. IVVO has recently announced their joint effort with Inverness Medical Innovations a leading manufacturer and marketer of rapid diagnostic products in order to complete development of the Prothrombin Time Monitor for its clinical trials.
Prothrombin Testing is a massive market and continues to grow with projections in excess of $150 million in 2005 and over $500 million by 2010. IVVO is poised to capitalize on this significant opportunity. Dont miss out on the near term upside potential in IVVO! 

INVESTMENT ANAYSIS 

In Vivo Medical Diagnostics, Inc. (Stock Symbol OTC: IVVO)
Short-Term Target: $3.00
12-Month Target: $5.00
Recommendations: Very Strong Buy
Long Term Outlook: Excellent 









Information within this email has been sent by a third party not affiliated wwith the company and contains "forward looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21B of the Securities Exchange Act of 1934. Any statements that express or involve discussions with respect to predictions, goals, expectations, beliefs, plans, projections, objectives, assumptions or future events or performance are not statements of historical fact and may be "forward looking statements. Please be advised that nothing within this email shall constitute a solicitation or an offer to buy or sell any security mentioned herein. This newsletter is neither a registered investment advisor nor affiliated with any broker or dealer. This newsletter is not affiliated with In Vivo Medical Diagnostics, Inc in any way. This newsletter was produced and distributed by a independent third party.  All statements made are our express opinion only and should be treated as such. We may own, buy and sell any securities mentioned at any time. This report includes forward-looking statements within the meaning of The Private Securities Litigation Reform Act of 1995. These statements may include terms as "expect", "believe", "may", "will", "move","undervalued" and "intend" or similar terms. PLEASE DO YOUR OWN DUE DILIGENCE BEFORE INVESTING IN ANY PROFILED COMPANY. You may lose money from investing in Penny Stocks.










. . . .  
  
  
  

. . . .  
  
  
.  .


